- Home
- GNRC vs BRKR Comparison
GNRC vs BRKR Comparison
Compare GNRC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNRC
- BRKR
- Stock Information
- Founded
- GNRC 1959
- BRKR 1991
- Country
- GNRC United States
- BRKR United States
- Employees
- GNRC N/A
- BRKR N/A
- Industry
- GNRC Metal Fabrications
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- GNRC Consumer Discretionary
- BRKR Industrials
- Exchange
- GNRC Nasdaq
- BRKR Nasdaq
- Market Cap
- GNRC 10.9B
- BRKR 9.2B
- IPO Year
- GNRC 2010
- BRKR 2000
- Fundamental
- Price
- GNRC $160.54
- BRKR $61.26
- Analyst Decision
- GNRC Buy
- BRKR Buy
- Analyst Count
- GNRC 20
- BRKR 13
- Target Price
- GNRC $177.78
- BRKR $75.67
- AVG Volume (30 Days)
- GNRC 665.9K
- BRKR 1.4M
- Earning Date
- GNRC 02-12-2025
- BRKR 02-11-2025
- Dividend Yield
- GNRC N/A
- BRKR 0.33%
- EPS Growth
- GNRC 89.80
- BRKR N/A
- EPS
- GNRC 4.82
- BRKR 2.06
- Revenue
- GNRC $4,124,703,000.00
- BRKR $3,241,300,000.00
- Revenue This Year
- GNRC $9.21
- BRKR $15.23
- Revenue Next Year
- GNRC $8.29
- BRKR $7.52
- P/E Ratio
- GNRC $33.32
- BRKR $30.54
- Revenue Growth
- GNRC 2.91
- BRKR 15.00
- 52 Week Low
- GNRC $108.89
- BRKR $48.07
- 52 Week High
- GNRC $195.94
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- GNRC 44.08
- BRKR 58.41
- Support Level
- GNRC $153.25
- BRKR $58.78
- Resistance Level
- GNRC $162.17
- BRKR $64.64
- Average True Range (ATR)
- GNRC 3.93
- BRKR 1.98
- MACD
- GNRC 1.06
- BRKR 0.39
- Stochastic Oscillator
- GNRC 76.61
- BRKR 59.23
About GNRC Generac Holdlings Inc.
Generac designs and manufactures power generation equipment serving residential, commercial, and industrial markets. It offers standby generators, portable generators, lighting, outdoor power equipment, and a suite of clean energy products. Sales generated in the United States account for the majority of total sales.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.